Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-16 Sale |
2024-08-19 5:29 pm |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
1,128 | $0.84 | $948 | 107,263 (Direct) |
View |
| 2024-08-05 Sale |
2024-08-06 4:15 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
24,480 | $1.0839 | $26,534 | 78,178 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 8:23 pm |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
939 | $0.94 | $883 | 51,674 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 8:18 pm |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
2,435 | $0.94 | $2,289 | 226,636 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 8:18 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
703 | $0.94 | $661 | 46,877 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 8:17 pm |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
891 | $0.94 | $838 | 96,295 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 8:16 pm |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
1,090 | $0.94 | $1,025 | 108,391 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 8:14 pm |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
843 | $0.94 | $792 | 151,609 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 9:48 pm |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
3,939 | $1.08 | $4,254 | 689,732 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 9:42 pm |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
11,549 | $1.08 | $12,473 | 1,795,401 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 9:31 pm |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
4,170 | $1.08 | $4,504 | 603,841 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 9:29 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
3,374 | $1.08 | $3,644 | 554,235 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 9:21 pm |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
4,400 | $1.08 | $4,752 | 589,893 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 9:15 pm |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
5,010 | $1.08 | $5,411 | 616,136 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-16 9:13 pm |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
3,939 | $1.08 | $4,254 | 751,597 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 9:43 pm |
Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks |
2,904 | $1.35 | $3,920 | 73,936 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 9:40 pm |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
8,552 | $1.35 | $11,545 | 199,132 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 9:40 pm |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
2,907 | $1.35 | $3,924 | 42,535 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 9:39 pm |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
4,066 | $1.35 | $5,489 | 215,383 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 9:39 pm |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
4,156 | $1.35 | $5,611 | 154,392 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 9:39 pm |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
4,066 | $1.35 | $5,489 | 101,072 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 9:36 pm |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
4,232 | $1.35 | $5,713 | 50,746 (Direct) |
View |
| 2023-10-30 Sale |
2023-10-31 9:36 pm |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
3,886 | $1.35 | $5,246 | 94,223 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-08-15 Exercise |
2024-08-19 5:29 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
2,969 | $0 | 107,263 (Direct) |
View |
| 2024-08-03 Exercise |
2024-08-06 4:15 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
85,000 | $0 | 78,178 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:15 pm |
N/A 2034-06-30 |
Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director |
64,564 | $0 | 64,564 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:15 pm |
N/A 2034-06-30 |
Seres Therapeutics Inc. | MCRB | Graves Kurt Director |
64,564 | $0 | 64,564 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:15 pm |
N/A 2034-06-30 |
Seres Therapeutics Inc. | MCRB | Berenson Stephen Director |
114,782 | $0 | 114,782 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 8:23 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
2,968 | $0 | 51,674 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 8:18 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
7,812 | $0 | 226,636 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 8:18 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
2,656 | $0 | 46,877 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 8:17 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
2,812 | $0 | 96,295 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 8:16 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
2,968 | $0 | 108,391 (Direct) |
View |
| 2024-05-15 Exercise |
2024-05-17 8:14 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
2,656 | $0 | 151,609 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 4:45 pm |
N/A 2034-04-03 |
Seres Therapeutics Inc. | MCRB | Graves Kurt Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 4:45 pm |
N/A 2034-04-03 |
Seres Therapeutics Inc. | MCRB | Kender Richard N Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 4:45 pm |
N/A 2034-04-03 |
Seres Therapeutics Inc. | MCRB | Biondi Paul Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 4:45 pm |
N/A 2034-04-03 |
Seres Therapeutics Inc. | MCRB | Fraser Claire Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 4:45 pm |
N/A 2034-04-03 |
Seres Therapeutics Inc. | MCRB | Dere Willard H Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 4:45 pm |
N/A 2034-04-03 |
Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-04-04 Option Award |
2024-04-08 4:45 pm |
N/A 2034-04-03 |
Seres Therapeutics Inc. | MCRB | Berenson Stephen Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 4:20 pm |
N/A 2034-03-24 |
Seres Therapeutics Inc. | MCRB | Thorell Marella See Remarks |
700,000 | $0 | 700,000 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 9:48 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
10,625 | $0 | 689,732 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 9:48 pm |
N/A 2034-02-13 |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
537,280 | $0 | 689,732 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 9:42 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
31,250 | $0 | 1,795,401 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 9:42 pm |
N/A 2034-02-13 |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
1,566,330 | $0 | 1,795,401 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 9:31 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
11,250 | $0 | 603,841 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 9:31 pm |
N/A 2034-02-13 |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
506,655 | $0 | 603,841 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 9:29 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
10,625 | $0 | 554,235 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 9:29 pm |
N/A 2034-02-13 |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
506,655 | $0 | 554,235 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 9:21 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
11,875 | $0 | 589,893 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 9:21 pm |
N/A 2034-02-13 |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
537,280 | $0 | 589,893 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 9:15 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
11,875 | $0 | 616,136 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 9:15 pm |
N/A 2034-02-13 |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
506,655 | $0 | 616,136 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 9:13 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
10,625 | $0 | 751,597 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 9:13 pm |
N/A 2034-02-13 |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
537,280 | $0 | 751,597 (Direct) |
View |
| 2023-10-27 Exercise |
2023-10-31 9:43 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks |
9,418 | $0 | 73,936 (Direct) |
View |
| 2023-04-27 Option Award |
2023-10-31 9:43 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks |
18,835 | $0 | 73,936 (Direct) |
View |
| 2023-10-27 Exercise |
2023-10-31 9:40 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
27,838 | $0 | 199,132 (Direct) |
View |
| 2023-04-27 Option Award |
2023-10-31 9:40 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President |
55,675 | $0 | 199,132 (Direct) |
View |
| 2023-10-27 Exercise |
2023-10-31 9:40 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
11,361 | $0 | 42,535 (Direct) |
View |
| 2023-04-27 Option Award |
2023-10-31 9:40 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks |
22,721 | $0 | 42,535 (Direct) |
View |
| 2023-10-27 Exercise |
2023-10-31 9:39 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
13,209 | $0 | 215,383 (Direct) |
View |
| 2023-04-27 Option Award |
2023-10-31 9:39 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer |
26,418 | $0 | 215,383 (Direct) |
View |
| 2023-10-27 Exercise |
2023-10-31 9:39 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
13,501 | $0 | 154,392 (Direct) |
View |
| 2023-04-27 Option Award |
2023-10-31 9:39 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP |
27,001 | $0 | 154,392 (Direct) |
View |
| 2023-10-27 Exercise |
2023-10-31 9:39 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
11,361 | $0 | 101,072 (Direct) |
View |
| 2023-04-27 Option Award |
2023-10-31 9:39 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks |
22,721 | $0 | 101,072 (Direct) |
View |
| 2023-10-27 Exercise |
2023-10-31 9:36 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
13,745 | $0 | 50,746 (Direct) |
View |
| 2023-04-27 Option Award |
2023-10-31 9:36 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks |
27,489 | $0 | 50,746 (Direct) |
View |
| 2023-10-27 Exercise |
2023-10-31 9:36 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
12,623 | $0 | 94,223 (Direct) |
View |
| 2023-04-27 Option Award |
2023-10-31 9:36 pm |
N/A N/A |
Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks |
25,245 | $0 | 94,223 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 5:35 pm |
N/A 2033-06-21 |
Seres Therapeutics Inc. | MCRB | Biondi Paul Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 5:29 pm |
N/A 2033-06-21 |
Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 5:25 pm |
N/A 2033-06-21 |
Seres Therapeutics Inc. | MCRB | Berenson Stephen Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 5:25 pm |
N/A 2033-06-21 |
Seres Therapeutics Inc. | MCRB | Fraser Claire Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 5:24 pm |
N/A 2033-06-21 |
Seres Therapeutics Inc. | MCRB | Behar Gregory Director |
35,000 | $0 | 35,000 (Direct) |
View |